These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25412756)

  • 1. Effects of Insulin Resistance on Myocardial Blood Flow and Arterial Peripheral Circulation in Patients with Polycystic Ovary Syndrome.
    Aldrighi JM; Tsutsui JM; Kowastch I; Ribeiro AL; Scapinelli A; Tamanaha S; Oliveira RM; Mathias W
    Echocardiography; 2015 Aug; 32(8):1277-84. PubMed ID: 25412756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
    Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
    Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
    Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
    Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
    Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
    Pepene CE; Ilie IR; Marian I; Duncea I
    Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
    Soyman Z; Noyan V; Tulmac M; Yucel A; Sagsoz N; Bayrak T; Bayrak A; Cakir E
    Fertil Steril; 2011 Mar; 95(3):1067-72. PubMed ID: 21193188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome.
    Yang B; Sun ZJ; Chen B; Zhang J; Zhao H; Li CW; Cao YK; Cao F
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1185-91. PubMed ID: 27049276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter.
    Gullu H; Erdogan D; Caliskan M; Tok D; Yildirim E; Ulus T; Turan Sezgin A; Muderrisoglu H
    Echocardiography; 2006 Nov; 23(10):835-42. PubMed ID: 17069601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome.
    Abali R; Tasdemir N; Alpsoy S; Tasdemir UG; Guzel S; Yuksel MA; Temel Yuksel I; Yilmaz M
    Arch Gynecol Obstet; 2015 May; 291(5):1075-80. PubMed ID: 25280574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.
    Mather KJ; Verma S; Corenblum B; Anderson TJ
    J Clin Endocrinol Metab; 2000 May; 85(5):1851-6. PubMed ID: 10843164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
    Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
    Soares GM; Vieira CS; Martins WP; Franceschini SA; dos Reis RM; Silva de Sá MF; Ferriani RA
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition.
    Sprung VS; Jones H; Pugh CJ; Aziz NF; Daousi C; Kemp GJ; Green DJ; Cable NT; Cuthbertson DJ
    Clin Sci (Lond); 2014 Jan; 126(1):67-74. PubMed ID: 23826984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
    Guleria AK; Syal SK; Kapoor A; Kumar S; Tiwari P; Dabadghao P
    Gynecol Endocrinol; 2014 Jan; 30(1):26-9. PubMed ID: 24020937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.